- Home
- JMM vs XTNT Comparison
JMM vs XTNT Comparison
Compare JMM & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMM
- XTNT
- Stock Information
- Founded
- JMM 1988
- XTNT N/A
- Country
- JMM United States
- XTNT United States
- Employees
- JMM N/A
- XTNT N/A
- Industry
- JMM Trusts Except Educational Religious and Charitable
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JMM Finance
- XTNT Health Care
- Exchange
- JMM Nasdaq
- XTNT Nasdaq
- Market Cap
- JMM 57.7M
- XTNT 55.6M
- IPO Year
- JMM N/A
- XTNT N/A
- Fundamental
- Price
- JMM $6.00
- XTNT $0.37
- Analyst Decision
- JMM
- XTNT Strong Buy
- Analyst Count
- JMM 0
- XTNT 1
- Target Price
- JMM N/A
- XTNT $3.00
- AVG Volume (30 Days)
- JMM 16.1K
- XTNT 225.5K
- Earning Date
- JMM 01-01-0001
- XTNT 11-12-2024
- Dividend Yield
- JMM 5.44%
- XTNT N/A
- EPS Growth
- JMM N/A
- XTNT N/A
- EPS
- JMM N/A
- XTNT N/A
- Revenue
- JMM N/A
- XTNT $113,862,000.00
- Revenue This Year
- JMM N/A
- XTNT $31.82
- Revenue Next Year
- JMM N/A
- XTNT $13.64
- P/E Ratio
- JMM N/A
- XTNT N/A
- Revenue Growth
- JMM N/A
- XTNT 45.11
- 52 Week Low
- JMM $5.29
- XTNT $0.33
- 52 Week High
- JMM $6.10
- XTNT $1.31
- Technical
- Relative Strength Index (RSI)
- JMM 40.73
- XTNT 29.03
- Support Level
- JMM $6.03
- XTNT $0.33
- Resistance Level
- JMM $6.16
- XTNT $0.39
- Average True Range (ATR)
- JMM 0.04
- XTNT 0.02
- MACD
- JMM -0.00
- XTNT 0.00
- Stochastic Oscillator
- JMM 5.88
- XTNT 46.78
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.